Location of Repository

Optimal protection of stabilised dry live bacteria from bile toxicity in oral dosage forms by bile acid adsorbent resins

By Alexander D. Edwards, Pratichi Chatterjee, Krishnaa T. Mahbubani, Cassilda M. Reis and Nigel K.H. Slater

Abstract

We previously found that dried live bacteria of a vaccine strain can be temporarily sensitive to bile acids and suggested that Bile Adsorbing Resins (BAR) can be used in oral vaccine tablets to protect dried bacteria from intestinal bile. Here, we report a quantitative analysis of the ability of BAR to exclude the dye bromophenol blue from penetrating into matrix tablets and also sections of hard capsule shells. Based on this quantitative analysis, we made a fully optimised formulation, comprising 25% w/w of cholestyramine in Vcaps™ HPMC capsules. This gave effectively 100% protection of viability from 4% bile, with 4200-fold more live bacteria recovered from this formulation compared to unprotected dry bacteria. From the image analysis, we found that the filler material or compaction force used had no measurable effect on dye exclusion but did affect the rate of tablet hydration. Increasing the mass fraction of BAR gave more exclusion of dye up to 25% w/w, after which a plateau was reached and no further dye exclusion was seen. More effective dye exclusion was seen with smaller particle sizes (i.e. cholestyramine) and when the BAR was thoroughly dried and disaggregated. Similar results were found when imaging dye penetration into capsule sections or tablets. The predictions of the dye penetration study were tested using capsules filled with dried attenuated Salmonella vaccine plus different BAR types, and the expected protection from bile was found, validating the imaging study. Surprisingly, depending on the capsule shell material, some protection was given by the capsule alone without adding BAR, with Vcaps™ HPMC capsules providing up to 174-fold protection against 1% bile; faster releasing Vcaps Plus™ HPMC capsules and Coni Snap™ gelatin capsules gave less protection

Publisher: Elsevier
Year: 2010
OAI identifier: oai:centaur.reading.ac.uk:7999

Suggested articles

Preview

Citations

  1. (2004). Alternative method for enteric coating of HPMC capsules resulting in ready-to-use enteric-coated capsules.
  2. (2007). Analysis and modeling of swelling and erosion behavior for pure HPMC tablet.
  3. (2005). Antibiotic-free plasmid stabilization by operator-repressor titration for vaccine delivery by using live Salmonella enterica Serovar typhimurium.
  4. (2005). Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria. doi
  5. (1991). Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines. doi
  6. (1959). Effect of an anion exchange resin on serum cholesterol in man.
  7. (2002). Enhancement of bile tolerance in lactococci by Tween 80. doi
  8. (2006). Enteric infections and the vaccines to counter them: future directions. doi
  9. (2008). Formulation of a live bacterial vaccine for stable room temperature storage results in loss of acid, bile and bile salt resistance.
  10. (1998). Measurement of rates of water penetration into tablets by microcalorimetry. doi
  11. (2009). Protection of live bacteria from bile acid toxicity using bile acid adsorbing resins.
  12. (2000). Stabilisation of Salmonella vaccine vectors by the induction of trehalose biosynthesis.
  13. (2000). Studies on adsorption characteristics of bile acids and methotrexate to a new type of anion-exchange resin, colestimide.
  14. (1994). Swelling and Drug-Release in Hydrogel Matrices - Polymer Viscosity and Matrix Porosity Effects.
  15. (2005). The interaction between bacteria and bile.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.